Cargando…
Proinsulin/Insulin Autoantibodies Measured With Electrochemiluminescent Assay Are the Earliest Indicator of Prediabetic Islet Autoimmunity
OBJECTIVE: We evaluated a novel electrochemiluminescent assay for insulin/proinsulin autoantibodies (ECL-IAA) as a new marker of the onset of islet autoimmunity and as a predictor of type 1 diabetes. RESEARCH DESIGN AND METHODS: The Diabetes Autoimmunity Study in the Young (DAISY) prospectively foll...
Autores principales: | Yu, Liping, Dong, Fran, Miao, Dongmei, Fouts, Alexandra R., Wenzlau, Janet M., Steck, Andrea K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714529/ https://www.ncbi.nlm.nih.gov/pubmed/23423694 http://dx.doi.org/10.2337/dc12-2245 |
Ejemplares similares
-
Electrochemiluminescence Assays for Human Islet Autoantibodies
por: Gu, Yong, et al.
Publicado: (2018) -
Islet Autoantibody Detection by Electrochemiluminescence (ECL) Assay
por: Gu, Yong, et al.
Publicado: (2017) -
GAD65 Autoantibodies Detected by Electrochemiluminescence Assay Identify High Risk for Type 1 Diabetes
por: Miao, Dongmei, et al.
Publicado: (2013) -
High-affinity ZnT8 Autoantibodies by Electrochemiluminescence Assay Improve Risk Prediction for Type 1 Diabetes
por: Jia, Xiaofan, et al.
Publicado: (2021) -
Distinguishing Persistent Insulin Autoantibodies With Differential Risk: Nonradioactive Bivalent Proinsulin/Insulin Autoantibody Assay
por: Yu, Liping, et al.
Publicado: (2012)